SUMMARY Cerebrospinal fluid from 100 patients with clinically diagnosed meningitis was examined for a-interferon. In the laboratory four patient groups were identified: bacterial meningitis (n = 12), viral meningitis (n = 15), normal cerebrospinal fluid (n = 57) and abnormal cerebrospinal fluid (n = 16). A further 14 patients with cerebrospinal fluid shunts but no abnormality in the cerebrospinal fluid provided a control group for ae-interferon determinations. The group with viral meningitis and the group with abnormal cerebrospinal fluid had significantly higher a-interferon concentrations (p < 0-001) when compared with those of the three other groups. This assay had great predictive value in determining those patients with abnormal cerebrospinal fluid who did not have a bacterial cause of meningitis. As the groups with abnormal cerebrospinal fluid and viral meningitis had a similar spread in a-interferon values it is likely that both reflect viral infection of the central nervous system.
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Viruses are a major cause of meningitis,' yet the usefulness of the virological examination of cerebrospinal fluid has been questioned.2 This is because the aetiological agent of an aseptic meningitis may only be identifiable in 20% of cases. Recently interferon in serum and cerebrospinal fluid has been shown to have high specificity for viral infections34 and was present despite the absence of specific neutralising antibody.5
In only one of these studies,4 however, was cerebrospinal fluid from cases of bacterial meningitis (two cases) tested for viral pathogens, and thus the previous reports of high concentrations of interferons in patients with bacterial meningitis69 cannot be fully substantiated.
Patients with meningitis pose important diagnostic and management problems. An early diagnosis of viral meningitis can result in a reduced hospital stay and prevent the prolonged use of antibiotics.2 The objective of this study was to evaluate the diagnostic value of a-interferon concentrations, using a highly specific monoclonal antibody technique'0 in 100 patients in whom meningitis was clinically suspected.
Patients and methods
This study was conducted prospectively over the winter months on patients with clinically diagnosed menAccepted for publication 21 July 1986 ingitis and in whom enough cerebrospinal fluid remained after routine isolation procedures for bacterial and viral pathogens. Cerebrospinal fluid was examined for a-interferon in 100 patients (48 females and 52 males aged 2 months to 37 years) and a control group of 14 patients (six females: eight males aged 2 months to 15 years) with cerebrospinal fluid shunts but no cerebrospinal fluid abnormality. Virus isolation from cerebrospinal fluid samples was undertaken in human embryonic lung fibroblasts, HEp 2, and secondary monkey kidney cells. Virus infection of monolayers was detected using standard techniques, with specific neutralising sera to identify isolates. Suckling mice were not used in these investigations. Laboratory results were then compared with clinical information and routine biochemical, bacteriological, and viral analysis of the cerebrospinal fluid. Other relevant information to the diagnosis of meningitis, such as positive serology or viral isolation from a sample of faeces, was also considered. The a-interferon concentrations in the cerebrospinal fluid of a further 14 patients with cerebrospinal fluid shunts were determined. As this group of patients were asymptomatic, had normal cerebrospinal fluid findings, and negative bacteriological and viral culture they were regarded as a control group.
The a-interferon assay was a two site immunoradiometric (IRMA) assay (Boots-Celltech), which was carried out according to the manufacturer's 84 Ho-Yen, Carrington *oa-interferon (+) when result > 15 lU/ml; **(<9 x 106/1); ***> 10 x 106/1).
instructions. In this assay a-interferon in the clinical specimen is captured by a radiolabelled highly specific monoclonal antibody (designated YOK 5/19 to IFN-a)10 and immobilised using a solid phase on which sheep anti-a-interferon is covalently coupled and provides a second epitope for a-interferon. The interassay and intra-assay reproducibility was confirmed in a series of 20 samples (0-100 IU/ml) to have a coefficient of variation of < 10%. In a series of additional experiments where specific neutralisation of ot-interferon was carried out, a cut off of 1[5 IU/ml was determined by sensitivity and specificity evaluations.
Results
Based Neisseria meningitidis (n = 4), Haemophilus influenzae (n = 2), Streptococcus pneumoniae (n = 1), Pseudomonas sp (n = 1), Klebsiella sp (n = 1), coliforms (n = 1), Mycobacterium tuberculosis (n = 1) and Lis- teria monocytogenes (n = 1). Viral causes of meningitis were: echovirus type 7 (n = 8), type 9 (n = 2), type 11 (n = 1), type 14 (n = 1), coxsackie A9 (n = 1), coxsackie B5 (n = 1) and mumps (n = 1). In the group with bacterial meningitis 11 patients had a cerebrospinal fluid with a predominant neutrophil count and in one case (Listeria monocytogenes) lym-
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Discussion
The methods used to measure interferon have been considerably improved. Until recently studies have used the plaque inhibition assay" -9 or a dye binding semi microassay.3 The IRMA assay, using a monoclonal antibody, which was also used in this study, is not only more sensitive but is also much more rapid. Previous methods took two days and normal ranges were considered to be < 10 IU/ml4 or < 12 IU/ml3. The method used in this paper took six hours, and normal ranges for control samples of cerebrospinal fluid were 1 5 IU/ml. Of our 28 abnormal interferon results, 24 were in the range 1-5 to 10 IU/ml. The increased sensitivity of the test, therefore, permitted the detection of abnormal interferon concentrations, which would have been previously classified as normal because of limitations in methodology. A rapid analysis of the cerebrospinal fluid also gives considerable advantages to the clinician in his decisions on the immediate management of the patient.
A major clinical problem is the differentiation of 85 bacterial and viral meningitis. One study7 showed raised cerebrospinal fluid interferon concentrations in 28 of 53 (52%) patients with bacterial meningitis. That study was atypical in several ways: eight of the 28 (29%) were fatal cases (four samples were obtained at necropsy), and 16 of 28 (57%) had a meningitis secondary to another disease (six malignancies), surgical, or diagnostic procedure. Viral culture was not performed, and it is impossible to determine how many patients had a coincident viral infection. Furthermore, the results of other studies have not supported these findings (table 2) . If our study and those of other workers48 9 are all taken together, there is an overall raised interferon concentration in only 8% of patients (table 2) . Of these five patients with bacterial meningitis, the organism responsible was Haemophilus influenzae in three and Listeria monocytogenes in two cases. In our study the two patients with H influenzae meningitis did not have raised a-interferon concentrations, but the one case of a-interferon (positive) bacterial meningitis was associated with L monocytogenes infection, as seen in one of the other studies.9 Interestingly, both of these patients had a cerebrospinal fluid in which lymphocytes were predominant. Thus it seems that raised interferon concentration in patients with bacterial meningitis is uncommon, but if found, the causative agent is likely to be H influenzae or L monocytogenes.
The objective of this study was to test the diagnostic value of the a-interferon assay applied to cerebrospinal fluid specimens. At present, the differential cell count, glucose, protein, and lactate concentrations are considered to be useful in the predictive differentiation of bacterial as opposed to viral meningitis. " In our cases the results of cx-interferon in cerebrospinal fluid were a better guide to viral meningitis than all other variables, including differential cell count in cerebrospinal fluid (table 1) . This is probably because early in viral meningitis there may be a predominance of neutrophils. In the patients with abnormal cerebrospinal fluid findings 13 had raised a-interferon concentrations, and it is likely that these patients had a viral meningitis. If this is so ax-interferon determinations may be a better indicator of viral infection of the central nervous system than virus isolation alone. We do not agree with Flowers and Scott4 that, "it is of no interest to the clinician if interferon is found to be present but it is subsequently not possible to identify a putative virus." We feel that clinicians will find it useful to have another measurement of cerebrospinal fluid which is more sensitive than virus isolation from the cerebrospinal fluid and more predictive of central nervous system infection than that of isolation from other sites."2
In our opinion the determination of a-interferon provides a useful discrimination between viral and
